Beijing Tiantan Biological Products Statistics

Total Valuation

Beijing Tiantan Biological Products has a market cap or net worth of CNY 46.94 billion. The enterprise value is 45.20 billion.

Market Cap	46.94B
Enterprise Value	45.20B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 20, 2024

Share Statistics

Beijing Tiantan Biological Products has 1.98 billion shares outstanding. The number of shares has increased by 0.45% in one year.

Shares Outstanding	1.98B
Shares Change (YoY)	+0.45%
Shares Change (QoQ)	-2.31%
Owned by Insiders (%)	2.81%
Owned by Institutions (%)	16.33%
Float	949.54M

Valuation Ratios

The trailing PE ratio is 37.22 and the forward PE ratio is 36.74. Beijing Tiantan Biological Products's PEG ratio is 2.16.

PE Ratio	37.22
Forward PE	36.74
PS Ratio	8.85
PB Ratio	4.55
P/FCF Ratio	39.68
PEG Ratio	2.16

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.16, with an EV/FCF ratio of 38.21.

EV / Earnings	35.62
EV / Sales	8.48
EV / EBITDA	20.16
EV / EBIT	23.19
EV / FCF	38.21

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.32.

Current Ratio	5.22
Quick Ratio	3.20
Debt / Equity	0.32
Debt / EBITDA	0.02
Debt / FCF	0.04
Interest Coverage	549.41

Financial Efficiency

Return on equity (ROE) is 13.52% and return on invested capital (ROIC) is 9.43%.

Return on Equity (ROE)	13.52%
Return on Assets (ROA)	8.40%
Return on Capital (ROIC)	9.43%
Revenue Per Employee	1.10M
Profits Per Employee	261,255
Employee Count	4,858
Asset Turnover	0.37
Inventory Turnover	0.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.49% in the last 52 weeks. The beta is 0.30, so Beijing Tiantan Biological Products's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+16.49%
50-Day Moving Average	24.26
200-Day Moving Average	24.20
Relative Strength Index (RSI)	44.68
Average Volume (20 Days)	7,000,095

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Beijing Tiantan Biological Products had revenue of CNY 5.33 billion and earned 1.27 billion in profits. Earnings per share was 0.64.

Revenue	5.33B
Gross Profit	2.90B
Operating Income	1.95B
Pretax Income	2.05B
Net Income	1.27B
EBITDA	2.22B
EBIT	1.95B
Earnings Per Share (EPS)	0.64

Full Income Statement

Balance Sheet

The company has 4.87 billion in cash and 43.53 million in debt, giving a net cash position of 4.83 billion or 2.44 per share.

Cash & Cash Equivalents	4.87B
Total Debt	43.53M
Net Cash	4.83B
Net Cash Per Share	2.44
Equity (Book Value)	13.41B
Book Value Per Share	5.22
Working Capital	6.65B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.33 billion and capital expenditures -1.15 billion, giving a free cash flow of 1.18 billion.

Operating Cash Flow	2.33B
Capital Expenditures	-1.15B
Free Cash Flow	1.18B
FCF Per Share	0.60

Full Cash Flow Statement

Margins

Gross margin is 54.47%, with operating and profit margins of 36.57% and 23.81%.

Gross Margin	54.47%
Operating Margin	36.57%
Pretax Margin	38.53%
Profit Margin	23.81%
EBITDA Margin	41.71%
EBIT Margin	36.57%
FCF Margin	22.19%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.53%.

Dividend Per Share	0.13
Dividend Yield	0.53%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	26.27%
Buyback Yield	-0.45%
Shareholder Yield	0.07%
Earnings Yield	2.69%
FCF Yield	2.52%

Dividend Details

Stock Splits

The last stock split was on June 20, 2024. It was a forward split with a ratio of 1.2.

Last Split Date	Jun 20, 2024
Split Type	Forward
Split Ratio	1.2